Pharmaceutical particulars : מידע רוקחי

6.    PHARMACEUTICAL PARTICULARS

6.1   List of excipients

Tamiflu 30 mg hard capsules
Capsule core
Pregelatinised starch
Talc
Povidone K30
Croscarmellose sodium
Sodium stearyl fumarate
Capsule shell
Gelatin
Titanium dioxide (E171)
Yellow iron oxide (E172)
Red iron oxide (E172)

Printing ink

Tamiflu 45 mg hard capsules
Capsule core
Pregelatinised starch
Talc
Povidone K30
Croscarmellose sodium
Sodium stearyl fumarate
Capsule shell
Gelatin
Titanium dioxide (E171)
Black iron oxide (E172)

Printing ink

Tamiflu 75 mg hard capsules
Capsule core
Pregelatinised starch
Talc
Povidone K30
Croscarmellose sodium
Sodium stearyl fumarate
Capsule shell
Gelatin
Titanium dioxide (E171)
Yellow iron oxide (E172)
Red iron oxide (E172)
Black iron oxide (E172)

Printing ink

6.2   Incompatibilities
Not applicable.

6.3   Shelf life
The expiry date of the product is indicated on the packaging materials.

6.4   Special precautions for storage

Do not store above 25 °C.

6.5   Nature and contents of container
Triplex blister pack (PVC/PE/PVDC, sealed with aluminium foil).
Pack-size 10 capsules.

6.6   Special precautions for disposal and other handling

Any unused product or waste material should be disposed of in accordance with local requirements.
7.    MARKETING AUTHORISATION HOLDER

Roche Pharmaceuticals (Israel) Ltd., 6 Hacharash, P.O. B. 6391, Hod Hasharon 4524079.

8.    LICENSE NUMBER(S)
Tamiflu Capsules 30 mg: 138 02 31733
Tamiflu Capsules 45 mg: 138 03 31734
Tamiflu Capsules 75 mg: 118 79 29952